EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Piezo1 deletion enhances cross-priming of CD8+ T cells by tumor-infiltrating CD11b+ dendritic cells

Melissa Bonner, David Askew, Vrishabhadev Sathish Kumar, Suzanne L Tomchuck, Saada Eid, Muta Abiff, Jay T Myers, Phuong Nguyen, Justin W A Garyu, Tyler E Miller, Alex Yee-Chen Huang

Journal for ImmunoTherapy of Cancer · 2025-06 · 13 (6) · e011815

DOI: 10.1136/jitc-2025-011815 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 23.06.2025. Verfasst von Melissa Bonner und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Ion Channels, CD8-Positive T-Lymphocytes, Dendritic Cells, Cross-Priming. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIGMS NIH HHS, Center for Pediatric Immunotherapy at the Angie Fowler AYA Cancer Institute, St. Baldrick’s Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tumor-associated myeloid cells (TAMCs) are an abundant, phenotypically plastic cell population that is critical for initiating a robust antitumor response. To properly combat cancer cells, TAMCs must sense and transduce both soluble and vital biophysical cues imparted by the dense extracellular matrix (ECM) of the tumor microenvironment (TME). Despite ample research enumerating the deleterious effects of a primary tumor’s ECM on TAMCs’ functionality, few studies have evaluated the contribution of mechanosensitive cation channel(s) underlying these detrimental changes.

Methods

Our study aimed to evaluate the significance of the mechanosensitive cation channel PIEZO1 in TAMCs’ phenotype and effector functionality. To do so, we generated CD11b-conditional Piezo1 knockout mice, orthotopically inoculated them with rhabdomyosarcoma 76–9, an aggressive syngeneic rhabdomyosarcoma cell line, and evaluated tumor burden, pan-immune compartment changes, and intrinsic myeloid and lymphoid transcriptomic and functional changes.

Results

Genetic deletion of Piezo1 in CD11b-expressing cells significantly hindered primary and metastatic tumor burden. Intratumorally, we observe enhanced infiltration of CD11b+ dendritic cells (DCs) and CD8+, but not CD4+, T cells. This phenotype was driven by CD11b+ DCs that have undergone transcriptional changes related to improved antigen presentation and T cell activation. Despite being canonically inefficient cross-presenters in the wildtype state, Piezo1 KO CD11b+ DCs, specifically the cDC2A subpopulation, efficiently cross-prime CD8+ T cells on exposure to exogenous particulate antigens.

Conclusions

Here, we report for the first time an association between mechanosensation and cross-presentation by cDC2A cells. Our findings may be impactful to improving the continued development of DC vaccines whose success hinges on proper antigen processing and presentation to cytotoxic T cells in the TME.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ion ChannelsCD8-Positive T-LymphocytesDendritic CellsCross-PrimingCD11b AntigenRhabdomyosarcomaAnimalsMiceTumor MicroenvironmentHumansMice, KnockoutCell Line, Tumor

Stichwörter der Autor:innen

Antigen PresentationDendritic CellsMyeloidSolid tumorTumor Microenvironment

Substanzen

Ion ChannelsCD11b AntigenPiezo1 protein, mouse

Autor:innen und Institutionen

  • Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
  • Department of Pediatrics, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
  • Department of Medicine, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
  • Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
  • Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA alex.y.huang@case.edu.
  • Center for Pediatric Immunotherapy, UH Rainbow Babies and Children's, Cleveland, Ohio, USA.

Förderung

  • NIGMS NIH HHS
  • Center for Pediatric Immunotherapy at the Angie Fowler AYA Cancer Institute
  • St. Baldrick’s Foundation
  • Children’s Cancer Research Fund
  • Theresia G. & Stuart F. Kline Family Foundation
  • NIH/ORIP
  • Colors for Colette Fund
  • Sam Day Foundation

Zitieren

APA

Bonner, M., Askew, D., Sathish Kumar, V., Tomchuck, S. L., Eid, S., Abiff, M., Myers, J. T., Nguyen, P., Garyu, J. W. A., Miller, T. E., & Huang, A. Y. (2025). Piezo1 deletion enhances cross-priming of CD8+ T cells by tumor-infiltrating CD11b+ dendritic cells. Journal for ImmunoTherapy of Cancer, 13(6), e011815. https://doi.org/10.1136/jitc-2025-011815

Vancouver

Bonner M, Askew D, Sathish Kumar V, Tomchuck SL, Eid S, Abiff M, et al. Piezo1 deletion enhances cross-priming of CD8+ T cells by tumor-infiltrating CD11b+ dendritic cells. Journal for ImmunoTherapy of Cancer. 2025;13(6):e011815. doi:10.1136/jitc-2025-011815

BibTeX
@article{Bonner2025,
  author = {Bonner, Melissa and Askew, David and Sathish Kumar, Vrishabhadev and Tomchuck, Suzanne L and Eid, Saada and Abiff, Muta and Myers, Jay T and Nguyen, Phuong and Garyu, Justin W A and Miller, Tyler E and Huang, Alex Yee-Chen},
  title = {Piezo1 deletion enhances cross-priming of CD8+ T cells by tumor-infiltrating CD11b+ dendritic cells},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2025},
  volume = {13},
  number = {6},
  pages = {e011815},
  doi = {10.1136/jitc-2025-011815}
}
Kostenlos starten →